Corrigendum to “Apoptosis induction and AKT/NF-κB inactivation are associated with regroafenib-inhibited tumor progression in non-small cell lung cancer in vitro and in vivo” [Biomed. Pharmacother. 116 (2019) 109032]

Corrigendum to “Apoptosis induction and AKT/NF-κB inactivation are associated with regroafenib-inhibited tumor progression in non-small cell lung cancer in vitro and in vivo” [Biomed. Pharmacother. 116 (2019) 109032]

Bibliographic Details
Main Authors: Mao-Chi Weng, Ming-Hsin Li, Jing Gung Chung, Yu-Chang Liu, Wu Jeng-Yuan, Fei-Ting Hsu, Hsin-Ell Wang
Format: Article
Language:English
Published: Elsevier 2019-10-01
Series:Biomedicine & Pharmacotherapy
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332219332433

Internet

http://www.sciencedirect.com/science/article/pii/S0753332219332433

Similar Items